Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Outpatient CPX-351 Induction in AML
NCT03988205Phase 4Terminated
- Sponsor
- Medical College of Wisconsin
- Start
- Aug 2019
- Primary completion
- Dec 2021
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Medical College of Wisconsin. Primary endpoints: Number of Participants Adherent to Recommendations at Day 60 and Number of Participants Adherent to Readmission Recommendations at Day 60. Started Aug 2019; status: terminated.
Beyond the preview
Go deeper on NCT03988205.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03988205.